Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Deloitte
Moodys
Federal Trade Commission
Mallinckrodt
Fish and Richardson
Citi
Farmers Insurance
Dow
Cerilliant

Generated: October 17, 2017

DrugPatentWatch Database Preview

EMVERM Drug Profile

« Back to Dashboard

What is the patent landscape for Emverm, and when can generic versions of Emverm launch?

Emverm is a drug marketed by Impax Labs Inc and is included in one NDA.

The generic ingredient in EMVERM is mebendazole. There are eight drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the mebendazole profile page.

Summary for Tradename: EMVERM

US Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list4
Bulk Api Vendors: see list81
Patent Applications: see list2,019
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:EMVERM at DailyMed

Pharmacology for Tradename: EMVERM

Drug ClassAntihelminthic
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Impax Labs Inc
EMVERM
mebendazole
TABLET, CHEWABLE;ORAL073580-001Jan 4, 1995RXNoYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Julphar
Mallinckrodt
Express Scripts
Citi
Cipla
Accenture
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot